Cantor Fitzgerald Reaffirms Its Overweight rating and $400 Price Target on Elevance Health, Inc. (ELV)
As 2026 Marketplace rates were set, Cantor Fitzgerald reaffirmed its Overweight rating and $400 price target, drawing attention to Elevance Health, Inc. (NYSE:ELV) on September 16, 2025.